M&A

Plastic Ingenuity announced today that it’s expanding its operations into Europe with the acquisition of Spezi-Pack. Located near Dresden, Germany, Spezi-Pack is an established thermoforming company. Madison, Wisconsin-based Plastic Ingenuity said the expansion enables it to offer regional European manufacturing for medical device and pharmaceutical packaging. The acquisition helps to increase efficiencies along the value…

AbbVie (NYSE: ABBV) recently announced that it has acquired a West Pharmaceutical Services (NYSE: WST) plant in Tempe, Arizona. North Chicago, Illinois–based AbbVie said on Jan. 12 that it plans to hire roughly 200 employees at the site and invest more than $175 million to acquire, modernize, and fully integrate the facility into its manufacturing…

Nelipak Corp. says it has acquired Merrill’s Packaging, which specializes in custom thermoformed packaging for medical devices, pharmaceuticals, and other life sciences products. Merrill’s has manufacturing operations at its Burlingame, California, headquarters and in Alajuela, Costa Rica. Both sites are ISO 13485 certified and have ISO Class 8 cleanrooms. “We are excited to welcome the…

GE HealthCare (Nasdaq:GEHC) announced today that it will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese radiopharmaceutical company. The purchase from Sumitomo Chemical is expected to close in early 2025, subject to regulatory approvals. Financial terms of the deal were not disclosed. GE HealthCare has already owned a…

Johnson & Johnson has sold off its remaining stake in the Kenvue consumer products business it spun off last year. In a filing with the SEC today, J&J said it brought in $3.6 billion for general corporate purposes from the transaction. Johnson & Johnson brought in the cash on May 15 after it issued a…

Bruker this week announced it entered into a definitive acquisition agreement with NanoString Technologies. Under the agreement’s terms, Bruker will substantially acquire all of the assets and rights associated with NanoString’s business for approximately $392.6 million in cash and the assumption of certain liabilities. The transaction was approved under a court-supervised Chapter 11 sale process…

Vertex Pharmaceuticals recently announced it will acquire Alpine Immune Sciences for $4.9 billion in cash. The two companies signed a definitive agreement in which Vertex will buy the biotech company for $65 per share. The transaction was unanimously approved by both companies’ boards of directors and is anticipated to close later this year. Alpine is…

Kintara Therapeutics and TuHURA recently announced they entered into a definitive merger agreement. The agreement is an all-stock transaction that will form a company with the expertise and resources needed to advance a risk-diversified late-stage oncology pipeline. The transaction is expected to close in Q3 2024. Kintara Therapeutics is a biopharmaceutical company investigating REM-001 in…

ProMed Pharma this week announced it acquired SpineThera’s manufacturing capabilities with the option to license intellectual property. Under the terms of the acquisition, ProMed Pharma has the option to license SpineThera’s microsphere intellectual property, which it could sublicense to ProMed Pharma’s customers. The Plymouth, Minnesota-based contract manufacturer will also add biodegradable microparticle development and manufacturing…

In the first few weeks of 2024, oncology remained a central focus area for M&A deals. Two major acquisitions, Johnson & Johnson’s purchase of Ambrx Biopharma and Merck & Co.’s acquisition of Harpoon Therapeutics, both focus on the segment. The trend is long-standing and was also apparent in 2023, as E&Y has noted. Merck was…